![]() The Guardian |
J&J drug shows promise in high-risk prostate cancer
Chicago Tribune (Reuters) – Adding Johnson & Johnson's advanced prostate cancer drug, Zytiga, to hormone therapy before surgery has been shown for the first time to eradicate tumors in some men with high-risk forms of the disease. The mid-stage trial found that six … Chemo Before Surgery Clears Prostate Cancer Britain to fund prostate cancer pill in U-turn |
View full post on prostate cancer – Google News
{ 0 comments }
